Designing Tomorrow´s Vaccines
SVF Vaccines develops vaccines and immunotherapies to prevent and treat life-threatening diseases based on technology developed at Karolinska Institute in Stockholm. Our most advanced program is a therapeutic vaccine for chronic hepatitis B and D infections, while Karolinska Institutet and the OpenCorona consortium are performing a Phase 1 study with SVF Vaccines' universal Covid-19 vaccine. Additional vaccines are in the discovery phase.
“The world is now more aware than ever of the transformative power of effective vaccines, and I’m very excited by the potential of SVF’s vaccine portfolio”